Search results for: biomaterials | Wyss Institute

Wyss Institute Search Site

View our 2023 Impact Report

Technologies 1

Implantable Cancer Vaccine
The implantable cancer vaccine is an aspirin-sized disc that is implanted under the skin and serves as an artificial lymph node, recruiting and training a patient's own immune cells to find and kill their cancer cells. It was validated in a Phase I clinical trial at the Wyss Institute, and is currently being developed by Novartis to treat melanoma.

News 3

Multimedia 3

Audio/Podcast

Engineering Adhesive Biomaterials to Improve Healing – ThinkResearch Podcast
Ben Freedman, Ph.D., discusses his research on the design and synthesis of adhesive biomaterials for applications in orthopedic and cardiovascular surgery, as well as neurosurgery.
Audio/Podcast

Immunoengineering with Dave Mooney – BIOS Podcast
Wyss Core Faculty member Dave Mooney is a leader in the fields of biomaterials, mechanotransduction, drug delivery, tissue engineering and immunoengineering. He is interested in understanding how cells sense signals in their environment and how this alters cell behavior. His laboratory develops biomaterials that exploit these signals to regulate specific cells and their function. They...
Video/Animation

Living Materials
Can we create a world of living materials that have the characteristics of biological systems: self-replication, self-regulation, self-healing, environmental responsiveness and self-sustainability? Engineered Living Materials (ELMs) are defined as engineered materials composed of living cells that form or assemble the material itself or modulate the functional performance of the material in some manner. The proposed Big...